Drug-delivered brain-to-brain network
Nanoparticles swallowed as a dose that self-assemble into a programmable interface in the brain, letting users share sensations, emotions and skills and run software on their own minds.
In shortDrug-delivered brain-to-brain network, from Nexus (Ramez Naam, 2012), is at technology readiness level 2 of 9 (technology concept formulated) at its weakest link. Held back by High-bandwidth brain-to-brain link and Cross-brain neural code alignment. Science status: consistent with known physics; key effects unproven at scale. Estimated new funding to unlock: $115B–575B (a floor; some parts are priced only to early research).
The Nexus 5 dose installs a wireless, programmable nano-interface in the user's neurons, enabling shared sensoria, transmitted skills and back-door control of other users.
Closest todayBrainNet's EEG-to-TMS binary link between three people; magnetoelectric nanoparticles that stimulate neurons wirelessly in mice.
Dependency stack
- Shared experience between users is the system's purpose
- Cross-brain translation is unsolved, so there is nothing meaningful to transmit
- Write bandwidth; non-invasive stimulation delivers of order one bit per second
- Latency and shared timing if the experience is to feel joint rather than relayed
- No authentication layer, so a shared channel is also a shared attack surface
plausibleTRL 2- Cross-brain neural code alignmentbottleneckSignals must be translated between two different neural codes
- Idiosyncratic coding; functional alignment currently needs both people to view the same long stimulus set
- No measurement of whether an aligned pattern evokes the same subjective content
- Channel capacity; achieved brain-to-brain bit rates are of order bits per minute
plausibleTRL 2- Alignment is composed of a decoder in one brain and an encoder in the other
✕3 blockers›
- Models are subject-specific; decoders do not transfer across brains without recalibration
- Non-invasive signals are slow and spatially coarse; invasive coverage is a few square centimetres
- Encoding (write) models are far behind decoding; we cannot specify the activity for an arbitrary percept
TRL 3- Fast, fine-grained signals needed for anything beyond coarse category decoding
✕2 blockers›
- Tissue response degrades signal over years
- Channel count and wireless bandwidth
TRL 6- Channel count is limited by wireless data and power budget
✕3 blockers›
- Tissue heating caps implant power at a few hundred milliwatts, which bounds radio and compute
- Raw broadband neural data exceeds the link, forcing on-implant spike detection and compression
- Battery or wireless-power lifetime versus the decades a permanent interface implies
TRL 5- Implant power density sets what telemetry and on-board compute are affordable
✕2 blockers›
- Cycle life of lithium-metal anodes
- Thermal runaway safety
TRL 6
- Deep generative and language models supply the latent spaces that brain activity is mapped onto
✕2 blockers›
- Reliability and calibration over long horizons
- Continual learning after deployment
TRL 7- Training and inference compute
✕2 blockers›
- Grid power and interconnection queues
- Advanced-node chip and HBM memory supply
TRL 8
- The receiving brain needs rich writing, not just a TMS pulse
✕4 blockers›
- Simultaneous stimulation and recording on the same tissue; stimulation artifact swamps spikes
- Coverage; immersive vision alone implies millions of controllable sites across V1
- Suppressing the real senses so the artificial stream is not in conflict with them
- Total implant power and heat once millions of channels are driven
plausibleTRL 3- Translating a synthetic scene into the activity patterns that evoke itTRL 3
- The write path for each sensory modality
✕4 blockers›
- Channel count and spatial resolution; phosphenes are coarse and do not tile a visual field
- Charge-density safety limits cap how often and how strongly tissue can be driven
- Stimulation artifacts blind the recording channels needed for closed-loop control
- No model specifies the pattern for an arbitrary complex percept
TRL 5- Stimulation needs the same dense chronic arrays as recordingTRL 6
- A full sensorium is a multi-gigabit bidirectional streamTRL 5
- Dense chronic coverage of multiple cortical areasTRL 6
- A shared neural channel must be authenticated to be usable at all
✕3 blockers›
- Implant power and latency budgets limit cryptographic strength and attestation
- Decoders leak content the user did not intend to transmit; filtering requires classifying intent
- No verified safety kernel that bounds stimulation regardless of compromised higher software
TRL 4- Security must fit inside the implant's power and bandwidth budgetTRL 5
- Transmitted skills and sensations must be translated between different brainsplausibleTRL 2
- An oral dose that becomes an interface is a self-assembling nanoscale device
✕3 blockers›
- No scheme to individually power and address millions of untethered sub-cellular devices
- Egress bandwidth; nanoparticles can stimulate but cannot yet report spikes off-board
- Clearance, aggregation and long-term toxicity of persistent intraparenchymal devices
plausibleTRL 3- Non-surgical delivery requires crossing from blood into brain parenchyma
✕3 blockers›
- Receptor targeting is species-specific; capsids binding human TfR1 often fail in macaque
- Pre-existing anti-AAV immunity excludes a large fraction of patients and blocks redosing
- Dose needed for brain-wide coverage drives liver toxicity and manufacturing cost
TRL 4- Designed capsid and shuttle proteins are the main route to receptor-specific transcytosis
✕1 blocker›
- Designing catalysis and conformational dynamics
TRL 6
- Devices resident in tissue for decades must not provoke encapsulation
✕3 blockers›
- Micromotion between rigid device and pulsating tissue drives chronic inflammation
- Thin-film encapsulation (polyimide, parylene, SiC) eventually admits water and fails
- Electrode charge-injection limits and corrosion under years of continuous stimulation
TRL 4
- The dose must cross from gut to bloodstream into neurons brain-wideTRL 4
- The plot turns on remote back doors into users' motor and emotional controlTRL 4
Who could unlock it
- Across several requirements:
- Rajesh Rao 2
- Alexander Huth 2
- Rajesh RaoResearcher, University of WashingtonCo-led BrainNet, the three-person EEG/TMS brain-to-brain link that solved a Tetris-like task (Scientific Reports 2019)
- Andrea StoccoResearcher, University of WashingtonCo-led the University of Washington human brain-to-brain interface experiments, including BrainNet (2019)
- Miguel NicolelisResearcher, Duke UniversityDemonstrated the first rat-to-rat brain-to-brain sensorimotor link with implanted electrodes (Scientific Reports 2013)
- Alexander HuthResearcher, University of Texas at AustinShowed semantic decoders can be transferred to new people via functional alignment (Current Biology 2025), a building block for cross-brain translation
- Alexander HuthResearcher, University of Texas at AustinTransferred semantic language decoders to new participants using functional alignment on stories or silent movies (Current Biology 2025)
- James HaxbyResearcher, Dartmouth CollegeDeveloped hyperalignment, the standard method for mapping fMRI representations between individuals
- Uri HassonResearcher, Princeton UniversityShowed speaker and listener brain activity couple during natural communication
- Jean-Rémi KingResearcher, Meta FAIRLeads Meta's brain-decoding team, including functional alignment of visual semantics across subjects and Brain2Qwerty MEG decoding (2025-2026)
- Deblina SarkarResearcher, MIT Media LabCirculatronics: immune-cell-electronics hybrids injected into the blood self-implanted in a target mouse brain region and were wirelessly powered (Nature Biotechnology 2025)
- Jacob RobinsonResearcher, Rice UniversityMagnetoelectric wireless power for distributed battery-free implant networks (Nature Biomedical Engineering 2025)
- Jia LiuResearcher, Harvard SEASCo-inventor of syringe-injectable mesh electronics; 2025 Nature Electronics paper on wireless ultrathin brain interfaces
- SynchronStartupEndovascular Stentrode in 10 patients by 2025; developing a transcatheter high-channel whole-brain interface
- Benjamin DevermanResearcher, Stanley Center for Psychiatric Research, Broad Institute of MIT and HarvardEngineered BI-hTFR1, an AAV9 capsid reprogrammed to bind human transferrin receptor, giving 40-50x more CNS expression than AAV9 in human TFRC knock-in mice (Science, 2024)
- Denali TherapeuticsCompanyIts TransportVehicle platform produced AVLAYAH (tividenofusp alfa), approved by the FDA in March 2026 as the first biologic specifically designed to cross the blood-brain barrier
- Voyager TherapeuticsCompanyUsed its TRACER platform to find cross-species BBB-penetrant capsids and identified ALPL as the receptor they use; VCAP-102 gave 20-400x more brain gene transfer than AAV9 in primates (2025)
- Sangamo TherapeuticsCompanyReported its STAC-BBB capsid achieving widespread brain transduction after intravenous dosing in non-human primates at clinically relevant doses (2024)
- Luciano FloridiResearcher, Yale Digital Ethics CenterCo-authored the 2025 Neuroethics analysis of BCI cyber risk recommending mandated non-surgical update paths, strong authentication and transit encryption
- Rafael YusteResearcher, Columbia UniversityFounder of the neurorights movement; drove the first hard-law neural-data protections, starting with Colorado HB 24-1058 in force August 2024
- Neurorights FoundationProgramCo-drafted the neural-data amendments enacted in Colorado, California, Montana and Connecticut (2024-2025) and briefed the FTC in April 2025
- MIND Act of 2025 (S.2925)ProgramCantwell/Schumer/Markey bill directing the FTC to assess neural-data security gaps and bar federal agencies from non-compliant neurotechnology
Beyond engineering
- Dual use, since the same interface can coerce as easily as connect
- Drug-law framing of a device that is swallowed rather than implanted